1. South Africa In Vitro Diagnostics Market Outlook to 2018-
Clinical Chemistry Genetic Testing, Haematology, Histology
and Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture
Report Details:
Published:December 2012
No. of Pages: 261
Price: Single User License – US$2500
South Africa In Vitro Diagnostics Market Outlook to 2018- Clinical Chemistry Genetic Testing,
Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and
Microbiology Culture
Summary
GlobalData’s new report, “South Africa In Vitro Diagnostics Market Outlook to 2018- Clinical
Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious
Immunology and Microbiology Culture” provides key market data on the South Africa In Vitro
Diagnostics market. The report provides value (USD million), volume (units) and average price
(USD) data for each segment and sub-segment within market categories – Immuno Chemistry,
Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology, Microbiology
Culture and Genetic Testing. The report also provides company shares and distribution shares
data for each of the aforementioned market categories. The report is supplemented with global
corporate-level profiles of the key market participants with information on company financials and
pipeline products, wherever available.
This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.
Scope
- Market size and company share data for In Vitro Diagnostics market categories – Immuno
Chemistry, Clinical Chemistry, Haematology, Infectious Immunology, Histology And Cytology,
Microbiology Culture and Genetic Testing.
- Annualized market revenues (USD million), volume (units) and average price (USD) data for

2. each of the segments and sub-segments within market categories. Data from 2004 to 2011,
forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories.
- Global corporate-level profiles of key companies operating within the South Africa In Vitro
Diagnostics market.
- Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott
Laboratories, Beckman Coulter, Inc., bioMerieux S.A., Ortho-Clinical Diagnostics Inc. and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for
strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the South Africa In Vitro
Diagnostics competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to
register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product
distribution – Identify, understand and capitalize.
Get your copy of this report @
http://www.reportsnreports.com/reports/213275-south-africa-in-vitro-diagnostics-market-outlook-to-2018-clinical-
chemistry-genetic-testing-haematology-histology-and-cytology-immuno-chemistry-infectious-immunology-and-
microbiology-culture.html
Major points covered in Table of Contents of this report include
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 17
2.1 What is This Report About? 17
3 In Vitro Diagnostics In South Africa 18
3.1 In Vitro Diagnostics, Market Segmentation 18
3.2 In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 19
3.3 In Vitro Diagnostics Market, South Africa, Revenue Mix ($m), 2011 21
3.4 In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2011 22
3.5 In Vitro Diagnostics, South Africa, Company Share (2010-2011) 29
4 Clinical Chemistry In South Africa 31
4.1 Clinical Chemistry, Market Segmentation 31
4.2 Clinical Chemistry Market, South Africa, Revenue Mix ($m), 2011 32
4.3 Clinical Chemistry Market, South Africa, Segment Contribution (%), 2011 33
4.4 Clinical Chemistry Overall Revenue, (2004-2018) 34
4.4.1 Clinical Chemisty Analyzers, Revenue (2004-2018) 38

3. 4.4.2 Urine Analysis, Revenue (2004-2018) 42
4.5 Clinical Chemistry Distribution Share (2010-2011) 46
4.6 Clinical Chemistry, South Africa, Company Share (2010-2011) 47
5 Genetic Testing In South Africa 49
5.1 Genetic Testing, Market Segmentation 49
5.2 Genetic Testing Market, South Africa, Revenue Mix ($m), 2011 50
5.3 Genetic Testing Market, South Africa, Segment Contribution (%), 2011 51
5.4 Genetic Testing Overall Revenue, (2004-2018) 52
5.5 Genetic Testing Distribution Share (2010-2011) 56
5.6 Genetic Testing, South Africa, Company Share (2010-2011) 57
6 Haematology In South Africa 59
6.1 Haematology Market, Market Segmentation 59
6.2 Haematology Market, South Africa, Revenue Mix ($m), 2011 60
6.3 Haematology Market, South Africa, Segment Contribution (%), 2011 61
6.4 Haematology Overall Revenue, (2004-2018) 62
6.4.1 Haematology Reagents, Revenue (2004-2018) 66
6.4.2 Immunohaematology, Revenue (2004-2018) 70
6.4.3 Haemostasis, Revenue (2004-2018) 74
6.4.4 Haematology Rapid Tests, Revenue (2004-2018) 78
6.4.5 Haematology Cell Counters, Revenue (2004-2018) 82
6.5 Haematology Distribution Share (2010-2011) 86
6.6 Haematology, South Africa, Company Share (2010-2011) 87
7 Histology And Cytology In South Africa 89
7.1 Histology and Cytology Market, Market Segmentation 89
7.2 Histology And Cytology Market, South Africa, Revenue Mix ($m), 2011 90
7.3 Histology And Cytology Market, South Africa, Segment Contribution (%), 2011 91
7.4 Histology And Cytology Overall Revenue, (2004-2018) 92
7.5 Histology And Cytology Distribution Share (2010-2011) 96
7.6 Histology And Cytology, South Africa, Company Share (2010-2011) 97
8 Immuno Chemistry In South Africa 99
8.1 Immuno Chemistry Market, South Africa, Revenue Mix ($m), 2011 99
8.2 Immuno Chemistry Market, South Africa, Segment Contribution (%), 2011 100
8.3 Immuno Chemistry Overall Revenue, (2004-2018) 102
8.3.1 Disease Specific Immunochemistry, Revenue (2004-2018) 106
8.3.2 Drugs of Abuse / Toxicology, Revenue (2004-2018) 110
8.3.3 Endocrinology Tests, Revenue (2004-2018) 114
8.3.4 Immunochemistry Rapid Tests, Revenue (2004-2018) 118
8.3.5 Therapeutic Drug Monitoring, Revenue (2004-2018) 122
8.3.6 Immunochemistry Analyzers, Revenue (2004-2018) 126
8.4 Immuno Chemistry Distribution Share (2010-2011) 130
8.5 Immuno Chemistry, South Africa, Company Share (2010-2011) 131
9 Infectious Immunology In South Africa 133

4. 9.1 Infectious Immunology, Market Segmentation 133
9.2 Infectious Immunology Market, South Africa, Revenue Mix ($m), 2011 134
9.3 Infectious Immunology Market, South Africa, Segment Contribution (%), 2011 135
9.4 Infectious Immunology Overall Revenue, (2004-2018) 136
9.4.1 Infectious Immunology Rapid Tests, Revenue (2004-2018) 140
9.5 Infectious Immunology Distribution Share (2010-2011) 144
9.6 Infectious Immunology, South Africa, Company Share (2010-2011) 145
10 Microbiology Culture In South Africa 147
10.1 Microbiology Culture, Market Segmentation 147
10.2 Microbiology Culture Market, South Africa, Revenue Mix ($m), 2011 148
10.3 Microbiology Culture Market, South Africa, Segment Contribution (%), 2011 149
10.4 Microbiology Culture Overall Revenue, (2004-2018) 150
10.4.1 Microbiology Analyzers, Revenue (2004-2018) 154
10.5 Microbiology Culture Distribution Share (2010-2011) 158
10.6 Microbiology Culture, South Africa, Company Share (2010-2011) 159
11 Overview of Key Companies in South Africa In Vitro Diagnostics Market 161
11.1 F. Hoffmann-La Roche Ltd. 161
11.1.1 Company Overview 161
11.1.2 Share in the South Africa In Vitro Diagnostics Market 161
11.2 Siemens Healthcare 162
11.2.1 Company Overview 162
11.2.2 Share in the South Africa In Vitro Diagnostics Market 162
11.3 Abbott Laboratories 163
11.3.1 Company Overview 163
11.3.2 Share in the South Africa In Vitro Diagnostics Market 163
11.4 Beckman Coulter, Inc. 164
11.4.1 Company Overview 164
11.4.2 Share in the South Africa In Vitro Diagnostics Market 164
11.5 bioMerieux S.A. 165
11.5.1 Company Overview 165
11.5.2 Share in the South Africa In Vitro Diagnostics Market 165
11.6 Ortho-Clinical Diagnostics Inc. 166
11.6.1 Company Overview 166
11.6.2 Share in the South Africa In Vitro Diagnostics Market 166
11.7 Mindray Medical International Limited 167
11.7.1 Company Overview 167
11.8 Becton, Dickinson and Company 167
11.8.1 Company Overview 167
11.9 Alere Inc. 168
11.9.1 Company Overview 168
11.10 Bio-Rad Laboratories, Inc. 168
11.10.1 Company Overview 168

5. 11.11 Qiagen N.V. 169
11.11.1 Company Overview 169
11.12 Grifols, S.A. 169
11.12.1 Company Overview 169
11.13 Sysmex Corporation 170
11.13.1 Company Overview 170
11.14 Horiba, Ltd. 170
11.14.1 Company Overview 170
11.15 Thermo Fisher Scientific Inc. 171
11.15.1 Company Overview 171
11.16 Trivitron Healthcare Pvt Ltd. 171
11.16.1 Company Overview 171
11.17 Gen-Probe Incorporated 172
11.17.1 Company Overview 172
11.18 DiaSorin S.p.A 172
11.18.1 Company Overview 172
11.19 Diagnostica Stago, Inc. 173
11.19.1 Company Overview 173
11.20 Phadia AB 173
11.20.1 Company Overview 173
11.21 Olympus Corporation 173
11.21.1 Company Overview 173
11.22 PerkinElmer, Inc. 174
11.22.1 Company Overview 174
11.23 Ani Labsystems Oy 174
11.23.1 Company Overview 174
11.24 Immucor, Inc. 175
11.24.1 Company Overview 175
11.25 Hologic, Inc. 175
11.25.1 Company Overview 175
11.26 Chembio Diagnostics, Inc. 176
11.26.1 Company Overview 176
11.27 Life Technologies Corporation 176
11.27.1 Company Overview 176
11.28 Danaher Corporation. 177
11.28.1 Company Overview 177
12 In Vitro Diagnostics Market Pipeline Products 178
12.1 Clinical Chemisty Market Pipeline Products 178
12.2 Immuno Chemistry Market Pipeline Products 181
12.3 Haematology Market Pipeline Products 192
12.4 Infectious Immunology Market Pipeline Products 194
12.5 Microbiology Culture Market Pipeline Products 201

6. 12.6 Histology And Cytology Market Pipeline Products 202
12.7 Genetic Testing Market Pipeline Products 203
13 Financial Deals Landscape 208
13.1 Partnerships 208
13.1.1 Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For
Archimedes Particle Metrology System 208
13.1.2 Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 209
13.1.3 BioDot Enters Into Co-Marketing Agreement With JOT Automation 210
13.1.4 BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology
Assays 211
13.1.5 CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital
Microscopy Hematology Solutions 212
13.1.6 Med BioGene Amends Licensing Agreement With Precision Therapeutics For LungExpress
Dx Test 213
13.1.7 Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon Biotechnology
214
13.1.8 Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 215
13.1.9 CML HealthCare Enters Into Agreement With MaRS Innovation 216
13.1.10 Castle Biosciences Enters Into Licensing Agreement With Brigham and Women''s Hospital
For Mesothelioma Test 217
13.1.11 Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein
Array Products 218
13.1.12 GeneCentric Diagnostics Enters Into Licensing Agreement With University of North
Carolina 219
13.1.13 NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For Oncotype
DX Tests 220
13.1.14 Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium TB
Test 222
13.1.15 SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For
PhenoFluor 223
13.1.16 Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 224
13.1.17 MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test 225
13.1.18 NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
226
13.1.19 Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 227
13.1.20 Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4 POC
Test 228
13.1.21 One Lambda Enters Into Co-Marketing Agreement With CellTrend 229
13.1.22 Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics For
ALK Cancer Biomarker 230
13.1.23 Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 231
13.1.24 Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG Marker

7. 232
13.1.25 Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor Cell
Technology 233
13.1.26 Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 234
13.1.27 Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For LongRange
PCR Kit 235
13.1.28 Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 236
13.1.29 Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For
Pressure Cycling Technology 237
13.1.30 LipoScience Enters Into Licensing Agreement With Cleveland Clinic 238
13.1.31 GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact
Cyclotron And PET Tracer System 239
13.1.32 Sysmex Extends Distribution Agreement With Roche 240
13.1.33 NexDx Enters Into Licensing Agreement With University of California For Epigenetic
Biomarkers 241
13.1.34 Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 242
14 Recent Developments 243
14.1 Strategy And Business Planning 243
14.1.1 Jul 24, 2012: Life Technologies And SATuRN Collaborate To Increase Access To HIV
Testing In Africa 243
14.2 Product News 244
14.2.1 Oct 17, 2011: Signature Mapping Receives Order For TBDx Automated Tuberculosis
Diagnostic Systems 244
14.2.2 Sep 14, 2011: Signature Mapping TBDx Tuberculosis Diagnostics Solution To Be Deployed
In Remote Intensive Case Finding Project 245
14.2.3 Jan 11, 2010: HairDX Forms Alliance For Distribution Of HairDX Genetic Test In South
Africa 245
15 Appendix 246
15.1 Definitions of Markets Covered in the Report 247
15.1.1 In Vitro Diagnostics 247
15.2 Research Methodology 258
15.3 Secondary Research 258
15.4 Primary Research 259
15.5 Models 259
15.6 Forecasts 260
15.7 Expert Panels 260
15.8 GlobalData Consulting 260
15.9 Currency Conversion 261
15.10 Contact Us 261
15.11 Disclaimer 261
1.1 List of Tables

8. Table 1: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 20
Table 2: In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2011 22
Table 3: In Vitro Diagnostics Market, South Africa, Cross-Category Analysis, 2004-2018 24
Table 4: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 26
Table 5: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Forecast, 2011-
2018 28
Table 6: In Vitro Diagnostics, South Africa, Company Share by Revenue ($m), USD Constant,
2010-2011 30
Table 7: Clinical Chemistry Market, South Africa, Segment Contribution (%), 2011 33
Table 8: Clinical Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 35
Table 9: Clinical Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 37
Table 10: Clinical Chemisty Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 39
Table 11: Clinical Chemisty Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 41
Table 12: Urine Analysis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 43
Table 13: Urine Analysis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 45
Table 14: Clinical Chemistry, South Africa, Distribution Share by Revenue ($m), USD Constant,
2010-2011 46
Table 15: Clinical Chemistry, South Africa, Company Share by Revenue ($m), USD Constant,
2010-2011 48
Table 16: Genetic Testing Market, South Africa, Segment Contribution (%), 2011 51
Table 17: Genetic Testing, South Africa, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 53
Table 18: Genetic Testing, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 55
Table 19: Genetic Testing, South Africa, Distribution Share by Revenue ($m), USD Constant,
2010-2011 56
Table 20: Genetic Testing, South Africa, Company Share by Revenue ($m), USD Constant, 2010-
2011 58
Table 21: Haematology Market, South Africa, Segment Contribution (%), 2011 61
Table 22: Haematology, South Africa, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 63
Table 23: Haematology, South Africa, Revenue ($m) USD Constant, by Segment, Forecast, 2011-
2018 65
Table 24: Haematology Reagents, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 67

9. Table 25: Haematology Reagents, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 69
Table 26: Immunohaematology, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 71
Table 27: Immunohaematology, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 73
Table 28: Haemostasis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 75
Table 29: Haemostasis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 77
Table 30: Haematology Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 79
Table 31: Haematology Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 81
Table 32: Haematology Cell Counters, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 83
Table 33: Haematology Cell Counters, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 85
Table 34: Haematology, South Africa, Distribution Share by Revenue ($m), USD Constant, 2010-
2011 86
Table 35: Haematology, South Africa, Company Share by Revenue ($m), USD Constant, 2010-
2011 88
Table 36: Histology And Cytology Market, South Africa, Segment Contribution (%), 2011 91
Table 37: Histology And Cytology, South Africa, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 93
Table 38: Histology And Cytology, South Africa, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 95
Table 39: Histology And Cytology, South Africa, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 96
Table 40: Histology And Cytology, South Africa, Company Share by Revenue ($m), USD
Constant, 2010-2011 98
Table 41: Immuno Chemistry Market, South Africa, Segment Contribution (%), 2011 101
Table 42: Immuno Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 103
Table 43: Immuno Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 105
Table 44: Disease Specific Immunochemistry, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 107
Table 45: Disease Specific Immunochemistry, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 109
Table 46: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 111

10. Table 47: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 113
Table 48: Endocrinology Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 115
Table 49: Endocrinology Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 117
Table 50: Immunochemistry Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 119
Table 51: Immunochemistry Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 121
Table 52: Therapeutic Drug Monitoring, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 123
Table 53: Therapeutic Drug Monitoring, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 125
Table 54: Immunochemistry Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 127
Table 55: Immunochemistry Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 129
Table 56: Immuno Chemistry, South Africa, Distribution Share by Revenue ($m), USD Constant,
2010-2011 130
Table 57: Immuno Chemistry, South Africa, Company Share by Revenue ($m), USD Constant,
2010-2011 132
Table 58: Infectious Immunology Market, South Africa, Segment Contribution (%), 2011 135
Table 59: Infectious Immunology, South Africa, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 137
Table 60: Infectious Immunology, South Africa, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 139
Table 61: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) USD Constant, by
Sub-Segment, Historic, 2004-2011 141
Table 62: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) USD Constant, by
Sub-Segment, Forecast, 2011-2018 143
Table 63: Infectious Immunology, South Africa, Distribution Share by Revenue ($m), USD
Constant, 2010-2011 144
Table 64: Infectious Immunology, South Africa, Company Share by Revenue ($m), USD Constant,
2010-2011 146
Table 65: Microbiology Culture Market, South Africa, Segment Contribution (%), 2011 149
Table 66: Microbiology Culture, South Africa, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 151
Table 67: Microbiology Culture, South Africa, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 153
Table 68: Microbiology Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 155

11. Table 69: Microbiology Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 157
Table 70: Microbiology Culture, South Africa, Distribution Share by Revenue ($m), USD Constant,
2010-2011 158
Table 71: Microbiology Culture, South Africa, Company Share by Revenue ($m), USD Constant,
2010-2011 160
Table 72: Clinical Chemisty Market Pipeline Products 178
Table 73: Immuno Chemistry Market Pipeline Products 181
Table 74: Haematology Market Pipeline Products 192
Table 75: Infectious Immunology Market Pipeline Products 194
Table 76: Microbiology Culture Market Pipeline Products 201
Table 77: Histology And Cytology Market Pipeline Products 202
Table 78: Genetic Testing Market Pipeline Products 203
Table 79: Affinity Biosensors Enters Into Distribution Agreement With Malvern Instruments For
Archimedes Particle Metrology System 208
Table 80: Agenix Enters Into Licensing Agreement With Tyrian Diagnostics For DiagnostIQ 209
Table 81: BioDot Enters Into Co-Marketing Agreement With JOT Automation 210
Table 82: BD Diagnostic Systems Enters Into Agreement With Lab21 To Develop New Oncology
Assays 211
Table 83: CellaVision Enters Into Distribution Agreement With Siemens Healthcare For Digital
Microscopy Hematology Solutions 212
Table 84: Med BioGene Amends Licensing Agreement With Precision Therapeutics For
LungExpress Dx Test 213
Table 85: Ovizio Imaging Systems Enters Into Distribution Agreement With Applikon
Biotechnology 214
Table 86: Life Technologies Enters Into Co-Marketing Agreement With Pathogenica 215
Table 87: CML HealthCare Enters Into Agreement With MaRS Innovation 216
Table 88: Castle Biosciences Enters Into Licensing Agreement With Brigham and Women''s
Hospital For Mesothelioma Test 217
Table 89: Scienion Enters Into Co-Marketing Agreement With Maine Manufacturing For Protein
Array Products 218
Table 90: GeneCentric Diagnostics Enters Into Licensing Agreement With University of North
Carolina 219
Table 91: NewBridge Pharma Enters Into Licensing Agreement With Genomic Health For
Oncotype DX Tests 220
Table 92: Epistem Enters Into Distribution Agreement With Becton Dickinson For Mycobacterium
TB Test 222
Table 93: SciFluor Life Sciences Enters Into Distribution Agreement With Sigma-Aldrich For
PhenoFluor 223
Table 94: Immuno-Biological Labs Enters Into Licensing Agreement With IBL International 224
Table 95: MDxHealth Enters Into Licensing Agreement With Merck For MGMT Diagnostic Test
225

12. Table 96: NicOx Enters Into Licensing Agreement With Rapid Pathogen Screening For AdenoPlus
226
Table 97: Immunexpress Enters Into Licensing Agreement With Debiopharm And Biocartis 227
Table 98: Omega Diagnostics Enters Into Licensing Agreement With Burnet Institute For CD4
POC Test 228
Table 99: One Lambda Enters Into Co-Marketing Agreement With CellTrend 229
Table 100: Clarient Diagnostic Services Enters Into Licensing Agreement With Insight Genetics
For ALK Cancer Biomarker 230
Table 101: Affymetrix Enters Into Technology Integration Agreement With Leica Microsystems 231
Table 102: Ventana Medical Enters Into Licensing Agreement With Gen-Probe For IP Of ERG
Marker 232
Table 103: Affymetrix Enters Into Distribution Agreement With ScreenCell For Circulating Tumor
Cell Technology 233
Table 104: Hycor Biomedical Enters Into Distribution Agreement With Roche For KOVA 234
Table 105: Genome Diagnostics Enters Into Co-Marketing Agreement With Qiagen For
LongRange PCR Kit 235
Table 106: Biofortuna Extends Co-Marketing Agreement With Abbott Labs For SSPGo 236
Table 107: Pressure BioSciences Enters Into Licensing Agreement With Target Discovery For
Pressure Cycling Technology 237
Table 108: LipoScience Enters Into Licensing Agreement With Cleveland Clinic 238
Table 109: GE Healthcare Enters Into Co-Development Agreement With NXT2B For Compact
Cyclotron And PET Tracer System 239
Table 110: Sysmex Extends Distribution Agreement With Roche 240
Table 111: NexDx Enters Into Licensing Agreement With University of California For Epigenetic
Biomarkers 241
Table 112: Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 242
1.2 List of Figures
Figure 1: In Vitro Diagnostics, Market Segmentation 18
Figure 2: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, 2004-2018 19
Figure 3: In Vitro Diagnostics Market, South Africa, Revenue Mix ($m), 2011 21
Figure 4: In Vitro Diagnostics Market, South Africa, Category Contribution (%), 2011 22
Figure 5: In Vitro Diagnostics Market, South Africa, Cross-Category Analysis, 2004-2018 23
Figure 6: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Historic, 2004-
2011 25
Figure 7: In Vitro Diagnostics, South Africa, Overall Revenue ($m), USD Constant, Forecast,
2011-2018 27
Figure 8: In Vitro Diagnostics, South Africa, Company Share (%), 2011 29
Figure 9: Clinical Chemistry, Market Segmentation 31
Figure 10: Clinical Chemistry Market, South Africa, Revenue Mix ($m), 2011 32
Figure 11: Clinical Chemistry Market, South Africa, Segment Contribution (%), 2011 33
Figure 12: Clinical Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Historic,

13. 2004-2011 34
Figure 13: Clinical Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 36
Figure 14: Clinical Chemisty Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 38
Figure 15: Clinical Chemisty Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 40
Figure 16: Urine Analysis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 42
Figure 17: Urine Analysis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 44
Figure 18: Clinical Chemistry, South Africa, Company Share (%), 2011 47
Figure 19: Genetic Testing, Market Segmentation 49
Figure 20: Genetic Testing Market, South Africa, Revenue Mix ($m), 2011 50
Figure 21: Genetic Testing Market, South Africa, Segment Contribution (%), 2011 51
Figure 22: Genetic Testing, South Africa, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 52
Figure 23: Genetic Testing, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 54
Figure 24: Genetic Testing, South Africa, Company Share (%), 2011 57
Figure 25: Haematology Market, Market Segmentation 59
Figure 26: Haematology Market, South Africa, Revenue Mix ($m), 2011 60
Figure 27: Haematology Market, South Africa, Segment Contribution (%), 2011 61
Figure 28: Haematology, South Africa, Revenue ($m) USD Constant, by Segment, Historic, 2004-
2011 62
Figure 29: Haematology, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 64
Figure 30: Haematology Reagents, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 66
Figure 31: Haematology Reagents, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 68
Figure 32: Immunohaematology, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 70
Figure 33: Immunohaematology, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 72
Figure 34: Haemostasis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Historic,
2004-2011 74
Figure 35: Haemostasis, South Africa, Revenue ($m) USD Constant, by Sub-Segment, Forecast,
2011-2018 76
Figure 36: Haematology Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 78
Figure 37: Haematology Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-

14. Segment, Forecast, 2011-2018 80
Figure 38: Haematology Cell Counters, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 82
Figure 39: Haematology Cell Counters, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 84
Figure 40: Haematology, South Africa, Company Share (%), 2011 87
Figure 41: Histology and Cytology Market, Market Segmentation 89
Figure 42: Histology And Cytology Market, South Africa, Revenue Mix ($m), 2011 90
Figure 43: Histology And Cytology Market, South Africa, Segment Contribution (%), 2011 91
Figure 44: Histology And Cytology, South Africa, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 92
Figure 45: Histology And Cytology, South Africa, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 94
Figure 46: Histology And Cytology, South Africa, Company Share (%), 2011 97
Figure 47: Immuno Chemistry Market, South Africa, Revenue Mix ($m), 2011 99
Figure 48: Immuno Chemistry Market, South Africa, Segment Contribution (%), 2011 100
Figure 49: Immuno Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 102
Figure 50: Immuno Chemistry, South Africa, Revenue ($m) USD Constant, by Segment, Forecast,
2011-2018 104
Figure 51: Disease Specific Immunochemistry, South Africa, Revenue ($m) USD Constant, by
Sub-Segment, Historic, 2004-2011 106
Figure 52: Disease Specific Immunochemistry, South Africa, Revenue ($m) USD Constant, by
Sub-Segment, Forecast, 2011-2018 108
Figure 53: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 110
Figure 54: Drugs of Abuse / Toxicology, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 112
Figure 55: Endocrinology Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 114
Figure 56: Endocrinology Tests, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 116
Figure 57: Immunochemistry Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 118
Figure 58: Immunochemistry Rapid Tests, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 120
Figure 59: Therapeutic Drug Monitoring, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 122
Figure 60: Therapeutic Drug Monitoring, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 124
Figure 61: Immunochemistry Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Historic, 2004-2011 126

15. Figure 62: Immunochemistry Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-
Segment, Forecast, 2011-2018 128
Figure 63: Immuno Chemistry, South Africa, Company Share (%), 2011 131
Figure 64: Infectious Immunology, Market Segmentation 133
Figure 65: Infectious Immunology Market, South Africa, Revenue Mix ($m), 2011 134
Figure 66: Infectious Immunology Market, South Africa, Segment Contribution (%), 2011 135
Figure 67: Infectious Immunology, South Africa, Revenue ($m) USD Constant, by Segment,
Historic, 2004-2011 136
Figure 68: Infectious Immunology, South Africa, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 138
Figure 69: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) USD Constant, by
Sub-Segment, Historic, 2004-2011 140
Figure 70: Infectious Immunology Rapid Tests, South Africa, Revenue ($m) USD Constant, by
Sub-Segment, Forecast, 2011-2018 142
Figure 71: Infectious Immunology, South Africa, Company Share (%), 2011 145
Figure 72: Microbiology Culture, Market Segmentation 147
Figure 73: Microbiology Culture Market, South Africa, Revenue Mix ($m), 2011 148
Figure 74: Microbiology Culture Market, South Africa, Segment Contribution (%), 2011 149
Figure 75: Microbiology Culture, South Africa, Revenue ($m) USD Constant, by Segment, Historic,
2004-2011 150
Figure 76: Microbiology Culture, South Africa, Revenue ($m) USD Constant, by Segment,
Forecast, 2011-2018 152
Figure 77: Microbiology Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Historic, 2004-2011 154
Figure 78: Microbiology Analyzers, South Africa, Revenue ($m) USD Constant, by Sub-Segment,
Forecast, 2011-2018 156
Figure 79: Microbiology Culture, South Africa, Company Share (%), 2011 159
Figure 80: F. Hoffmann-La Roche Ltd., Company Share (%),South Africa In Vitro Diagnostics
Market, 2011 161
Figure 81: Siemens Healthcare, Company Share (%),South Africa In Vitro Diagnostics Market,
2011 162
Figure 82: Abbott Laboratories, Company Share (%),South Africa In Vitro Diagnostics Market,
2011 163
Figure 83: Danaher Corporation, Company Share (%),South Africa In Vitro Diagnostics Market,
2011 164
Figure 84: bioMerieux S.A., Company Share (%),South Africa In Vitro Diagnostics Market, 2011
165
Figure 85: Ortho-Clinical Diagnostics Inc., Company Share (%),South Africa In Vitro Diagnostics
Market, 2011 166
Contact: sales@reportsandreports.com for more information.